Boehringer Ingelheim International GMBH;Neurocrine Biosciences, INC.
发明人:
Brian Dyck,Chen Cheng,Florence Jovic,Joe A. Tran,Junko Tamiya,Neil J. Ashweek,Nicole Harriott,Timothy Coon,Troy Vickers
申请号：
BR112012000831
公开号：
BR112012000831A2
申请日:
2010.06.23
申请国别(地区):
BR
年份:
2019
代理人:
摘要：
New compounds are disclosed which have utility in the treatment of a variety of metabolic related conditions in a patient. The compounds of this invention have the structure (I): wherein R1, R2, R3, n, p, q, and Ar are as defined herein, including stereoisomers, and pharmaceutically acceptable salts thereof. Also disclosed are pharmaceutical compositions comprising a compound of this invention, as well as methods relating to the use thereof in a patient in need thereof.
